James Kirkpatrick (born November 1970) is a board-certified American cardiologist in Seattle, Washington. He is the Director of the Echocardiography Lab at the University of Washington Medical Center.
James Kirkpatrick Facts
- Full Name: James Neal Kirkpatrick
- Age: 52years old
- Date of Birth: November 1970
- Occupation: Cardiologist
- Nationality: American
James Kirkpatrick Medical School & Residency
- University of Chicago Medical Center – Fellowship, Cardiovascular Disease, 2003-2006
- Yale-New Haven Hospital – Residency, Internal Medicine, 1998-2001
- Loma Linda University School of Medicine – Medical School
James Kirkpatrick Career
Kirkpatrick is one of the few cardiologists in the United States with ethics training and specializes in ultrasound imaging of left ventricular assist devices.
Certifications & Licensure
- American Board of Internal Medicine – Certified in Internal Medicine
- American Board of Internal Medicine – Certified in Cardiovascular Disease
- IL State Medical License – Active through 2008
- CA State Medical License – Active through 2016
- PA State Medical License – Active through
- WA State Medical License – Active through 2022
- UW Medicine-University of Washington Medical Center, Seattle, WA
Dr. James Neal Kirkpatrick has the following 36 areas of expertise
- Acute Coronary Syndrome (ACS)
- Cardiovascular Disease
- Thyroid Cancer
- Left Ventricular Dysfunction
- Impotence (Vasculogenic Impotence)
- Heart Valve Diseases
- Heart Block
- Cardiac Arrhythmias
- Stress Echocardiography
- Unstable Angina
- Aortic Aneurysm
- Atrial Fibrillation
- Blood Clot
- Coronary Artery Disease (CAD)
- High Cholesterol
- Myocardial Diseases
- Aortic Diseases
- Heart Attack
- Percutaneous Arterial Septic Defect (ASD) Closure
- High Blood Pressure (Hypertension)
- Angina (Angina Pectoris)
- Heart Failure
- Heart Disease (Myocardial Ischemia)
- High Cholesterol (Hypercholesterolemia)
- Lipid Disorders
- Heart Diseases
- Sinus Arrhythmia
- Aetna Choice POS II
- Aetna Managed Choice POS Open Access
- Aexcel PPO
- BCBS Blue Card PPO
- CIGNA HMO
- CIGNA LocalPlus
- CIGNA Open Access Plus
- CIGNA PPO
- First Choice
- First Health PPO
- Heritage Prime
- Individual Signature
- MEDICA CHOICE WITH UNITEDHEALTHC
- Molina place WA
- Multiplan PPO
- Preferred Provider Network – WA
- Premera Heritage and Heritage Plus 1
- Premera Heritage Signature
- UHC Choice Plus POS
- UHC Nexus Open Access
- UHC Options PPO
- UHC Signature Value
- UW Medicine Accountable Care Network
Location & Contact Information
Heart Institute At University Of Washington Medical Center
1959 NE Pacific St
Seattle, WA 98195
Data provided by the National Library of Medicine
- Assessment of global and regional left ventricular diastolic function in hypertensive heart disease using automated border detection techniques.
- Medical house officers’ attitudes toward vigorous analgesia, terminal sedation, and physician-assisted suicide.
- Golden rule reasoning in clinical medicine: theoretical and empirical aspects.
- Clinical utility of automated assessment of left ventricular ejection fraction using artificial intelligence-assisted border detection.
- Effects of cardiac resynchronization therapy on ventricular remodeling.
- Hand-carried echocardiography for assessment of left ventricular filling and ejection fraction in the surgical intensive care unit.
- Analyzing the “speckled band” to predict response to CRT: a Sherlockian conundrum.
- Using echo to evaluate patients with left ventricular assist devices (LVADs):
- Safety and efficacy of pacemaker reuse in underdeveloped nations: a case series.
- Echocardiographic strain imaging and its use in the clinical setting.
- Transthoracic and transesophageal echocardiography for the indication of suspected infective endocarditis: vegetations, blood cultures and imaging.
- Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure.
- Accuracy of noninvasively determined pulmonary artery systolic pressure.
- ABCD’s of heart failure: echo-ing through the first stage.
- Recovery of pacemakers and defibrillators for analysis and device advance directives: electrophysiologists’ perspectives.
James Kirkpatrick Net Worth
James Kirkpatrick has an estimated net worth of $6 million.